Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Beam Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2017 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.93B
Market cap · Apr/2026
Revenue
$56M
Latest reported FY

Investors

10 investors on Beam Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 10 investors entered at this stage
Harvard University
Dreamers
Omega Funds
DHVC
Altitude Life Science Ventures
Redmile Group
Cormorant Asset Management
F-Prime
Eight Roads Ventures
ARCH Venture Partners

Global footprint

Where Beam Therapeutics has talent and traffic

AI talent share
0.9% of workforce is AI talent
(5 of 573 staff)
Core AI10.17%
Other AI40.7%
Non-AI workforce56899.13%
Web traffic by country
43K monthly visits
across markets
🇺🇸 United States70.7%
🇨🇦 Canada7%
🇬🇧 United Kingdom6.5%
🇮🇳 India4.7%
🏳️ Korea4%
Top 5 markets shown

Patent intelligence

$18M patent portfolio · 87 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$18M
0.92% of market cap · 13.4× smaller than top peer Juno Therapeutics ($239M)
87 active patent families
Where Beam Therapeutics innovates Cell biologyMolecular biologyPolynucleotideBase JCell
Tracks the peer median across all five Patsnap quality dimensions.

Quality vs same-sector peers

Beam Therapeutics on the five Patsnap quality dimensions

Beam Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Beam Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Beam Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Beam Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo